Strongbridge Biopharma adds Jeffrey Sherman to board of directors
Dr. Sherman has more than 25 years of research, clinical development, regulatory and commercialization experience within the biopharmaceutical industry.
Since 2009, he has served as chief medical officer and an executive vice president at Horizon Pharma.
He also previously held senior leadership positions at IDM Pharma, Takeda Global Research and Development, NeoPharm, Searle/Pharmacia, Bristol-Myers Squibb, and is a past president of the Drug Information Association (DIA).
Dr. Sherman earned his M.D. from the Rosalind Franklin University of Medicine and Science/The Chicago Medical School.
He completed internship and residency programs at Northwestern University Feinberg School of Medicine, where he currently serves as an adjunct assistant professor, and a fellowship position at the University of California San Francisco.
He received a B.A. in Biology from Lake Forest College. ■
LATEST MOVES FROM Ireland
- Greencore appoints Kevin F. O'Malley as director
- Bank of Ireland director Brad Martin to step down
- Permanent TSB Group appoints Robert Elliott as chairman
- Mincon Group appoints John Doris as director
- Permanent TSB Group appoints Eamonn Crowley as CFO
More inside POST
New CEOs have 100 days to boost stock prices Leadership